Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018
Use of Antiepileptic Drugs during Pregnancy and Risk of Spontaneous Abortion and Stillbirth: Population Based Cohort Study
BMJ 349:g5159, Bech, B.H.,et al, 2014
Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010
Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006
Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005
Antiphospholipid Antibodies in Patients without Systemic Lupus Erythematosus:Neuroradiologic Findings
Radiology 192:531-537, Provenzale,J.M.,et al, 1994
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Cerebral Venous Thrombosis in Systemic Lupus Erythematosus
Stroke 21:1226-1231, Vidailhet,M.,et al, 1990
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987